Calcium channel blockers are an important group of drugs that have been used in the treatment of cardiovascular disorders, especially hypertensive states. In this study we have investigated the effects of three newly synthesized ester analogs of nifedipine on mean arterial blood pressure (MAP), cardiac contractility index (dp/dt) and heart rate (HR) in normal rabbits and in rabbits with hypertension.Animals (n=24) were divided into three groups (n=8) and anesthetized with diazepam (1.7 mg/kg) and sodium pentobarbital (30 mg/kg). The right femoral vein and artery were cannulated for further injections (phenylephrine and sodium pentobarbital) and recording of arterial blood pressure respectively. Right jugular vein was cannulated for injection of test compounds. Another cannula was inserted in right carotid artery and pushed to left ventricle to record intraventricular pressure. Ventricular dp/dt was calculated as an index of cardiac contractility. Test compounds and nifedipine were tested in two groups. In the first group, 1 ml of nifedipine (10-4M) was injected through the jugular vein for one minute. Five minutes later, 1 ml of test compounds was injected. Then, the effects of I ml of nifedipine at a g.oncentrationof 10-3M and test compounds were investigated. In the second group, arterial blood pressure was increased by 20 mmHg/min through infusion of phenylephrine (2 x 10-5 M at a rate of 1.5-2 ml/min) and then experiments of first group were repeated in hypertensive condition.Our results showed that in normotensive conditions, nifedipine (10-3 M) reduced MAP and dp/dt and increased HR by 10, 12.5 and 3% respectively and in hypertensive conditions, nifedipine reduced MAP and dp/dt and increased HR by 16.1, 19.5% and 3.4% respectively. In addition, compound No. 1 reduced the same indices by 4, 8.4, and 1.4% respectively, in normotensive state and by 10, 14.1, and 3% in hypertensive state, compound No. 2 reduced these indices by 14.1, 5.5, and 8.5% in normotensive state and by 16.5, 4.9, and 4.2% in hypertensive state, and compound No. 3 decreased variables by 10.8, 12.7, and 8.6% in normotensive state and by 20.8, 7.9, and 4.9% in hypertensive state respectively. In hypertensive conditions compounds No. 2 and No. 3 reduced heart rate in contrast to nifedipine (P<0.05). The effect of these three compounds (10-4 M) was non-significantly lower than nifedipine at the same concentration.Since compounds No. 2 and No.3 reduced blood pressure and cardiac contractility similar to nifedipine and meanwhile reduced heart rate non-significantly more than nifidipine, therefore they are probably preferred in the treatment of hypertensive patients with coronary artery disease.